chitosan has been researched along with Moniliasis, Oral in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, GDSG; Araujo, HC; Dos Santos Oliveira, M; Monteiro, DR; Morato, DN; Pessan, JP; Ramírez Carmona, W; Sato, C | 1 |
| Abe, M; Abe, S; Hayama, K; Hirano, S; Kageshima, H; Murakami, Y; Saito, A; Takahashi, M; Yamada, T | 1 |
| Kaomongkolgit, R; Ngawhirunpat, T; Opanasopit, P; Panomsuk, S; Rojanarata, T; Tonglairoum, P | 1 |
| Antonio Julián, B; Carmen, GM; Fabio, CA; Francisco, C; Jesús, S; Leonor, PL; Yolanda, MB | 1 |
| Eraç, B; Ertan, G; Güneri, P; Gurer-Orhan, H; Hoşgör-Limoncu, M; Karavana, SY; Nenni, M; Özbal, S; Pekçetin, Ç; Rençber, S; Yılmaz, FF | 1 |
| Barrera, MG; Frattini, A; Lamas, MC; Leonardi, D; Piccirilli, GN; Salomón, CJ; Sortino, M; Tejada, G | 1 |
| Azcurra, A; Barembaum, S; Bojanich, A; Calamari, S; Dorronsoro, S; Virga, C | 1 |
7 other study(ies) available for chitosan and Moniliasis, Oral
| Article | Year |
|---|---|
In vitro antimicrobial effects of chitosan on microcosm biofilms of oral candidiasis.
Topics: Acrylic Resins; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Chitosan; Chlorhexidine; Humans; Lactic Acid; Miconazole; Nystatin; Stomatitis, Denture | 2022 |
Inhibition of Growth of Candida albicans by a Lysozyme-chitosan Conjugate, LYZOX and its Combination with Decanoic Acid.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chitosan; Decanoic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Mice, Inbred ICR; Muramidase; Treatment Outcome | 2017 |
Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis.
Topics: Adhesives; Administration, Oral; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Cell Line; Chitosan; Clotrimazole; Cyclodextrins; Delayed-Action Preparations; Drug Delivery Systems; Humans; Povidone; Transdermal Patch | 2015 |
Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chitosan; Disease Models, Animal; Epithelium; Female; Methylene Blue; Mice; Mice, Inbred DBA; Mucous Membrane; Nystatin; Photochemotherapy; Photosensitizing Agents; Random Allocation | 2016 |
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cattle; Chitosan; CHO Cells; Cricetulus; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Stability; Fluconazole; Male; Mouth Mucosa; Nanoparticles; Particle Size; Polymethacrylic Acids; Rabbits | 2016 |
Development and Evaluation of Buccal Films Based on Chitosan for the Potential Treatment of Oral Candidiasis.
Topics: Adhesiveness; Administration, Buccal; Antidiarrheals; Antifungal Agents; Candidiasis, Oral; Chitosan; Drug Compounding; Drug Delivery Systems; Humans; Hypromellose Derivatives; Miconazole; Microscopy, Electron, Scanning; Pectins; Polymers; X-Ray Diffraction | 2017 |
[High molecular weight chitosan and sodium alginate effect on secretory acid proteinase of Candida albicans].
Topics: Alginates; Candida albicans; Candidiasis, Oral; Cell Adhesion; Chitosan; Drug Evaluation, Preclinical; Endopeptidases; Fungal Proteins; Glucuronic Acid; Hexuronic Acids; Humans; Molecular Weight; Protease Inhibitors | 2004 |